Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Shandong Wohua Pharmaceutical Co Ltd

002107.SZ ✓ COMPLIANTFree checks used up today ☆ Track — members

Shenzhen Stock Exchange · Healthcare · Pharmaceuticals ·

China Small Cap Analyst: N/A

Last Close

$0.87

▲ +0.34%

Market Cap $504.33M · Vol 8.93M

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

27.01

FWD: N/A

Market Cap

$504.33M

Small Cap

Div Yield

4.52%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

13.97

Momentum

Beta

0.66

vs Market

52W High

$1.27

29.67% below

52W Low

$0.82

8.52% above

Volume

8.93M

Avg 15.84M

P/B

4.90

Price-to-book

ROE

N/A

Return on equity

Free Float

45.99%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Shandong Wohua Pharmaceutical Co Ltd (002107.SZ) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 002107.SZ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.90%

-17.91%

-2.18%

-20.38%

YTD

-6.73%

-4.43%

-2.56%

-6.28%

Financials & Valuation

TTM · Annual

Total Revenue	$116.82M
Net Income	$12.70M
Revenue Growth (YoY)	-7.53%
Gross Margin	75.14%
Operating Margin	11.98%
Net Profit Margin	10.87%
ROE	N/A
ROA · ROIC	10.43% · 12.93%

P/E Ratio	27.01
Forward P/E (FY1)	N/A
PEG Ratio	0.23
P/S	4.41
P/B	4.90
P/FCF	28.21
EPS Growth	N/A
Outstanding Shares	577.21M

Technical Indicators

50-Day SMA	$1.00
200-Day SMA	$1.01
RSI (14)	13.97
Beta	0.66
52-Week High	$1.27
52-Week Low	$0.82

Volume Today	8.93M
Avg Daily Volume (30D)	15.84M
Relative Volume	0.56x
Volatility (10D)	27.85
Volatility (30D)	41.14
Free Float	45.99%

Analyst Consensus

N/A

Current Price $0.87

Mean Target N/A

52W Low$0.82 52W High$1.27

Current

Target

$0.82 $1.27

Current Analyst target

· 0 analysts

Identifiers

ExchangeShenzhen Stock Exchange

FIGIBBG001SSB6J9

ISINCNE000001QB8

CountryChina

Sub-IndustryAlternative Medicine

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

000538.SZ Yunnan Baiyao Group Co Ltd +1.47% 600085.SS Beijing Tong Ren Tang Co Ltd +2.62% 000423.SZ Dong-E-E-Jiao Co Ltd +1.27% 600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited +0.80% 002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd +1.57%

Company Profile

Shandong Wohua Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sale of Chinese patent medicines. The Company's cardiovascular and nervous system drug products include Wohua Xinkeshu Tablets, Hedan Tablets and Capsules, Naoxueshu Oral Liquid, Tongluo Huatan Capsules, Shenzhiling Oral Liquid and others. The Company's musculoskeletal system drug products include Gushukang Capsules and Granules, Yuandu Hanbi Liquid and others. The Company's reproductive and urinary system drug products include Hupoxiaoshi Granules and others. The Company's respiratory system drug products include Xiaoer Tuire Granules, Fufang Xiling Jiedu Tablets, Yuandu Ganmao Granules, Yinhuang Granules and others. The Company mainly conducts its business in the domestic market.